A ten-year audit of traditional Chinese medicine and other natural product research published in the

来源 :中华医学杂志(英文版) | 被引量 : 0次 | 上传用户:ltt3221340
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background Clinical research encompasses a wide variety of disciplines. Traditional Chinese medicine (TCM) and natural product research have made great contributions to preventing and treating illness. The number and content of original research reports evaluating TCM and natural products have not previously been described. Information in this area will identify areas of relative strength and weakness in terms of knowledge gaps with respect to clinical conditions and natural product remedies.Methods Original research reports (i.e. original articles, brief reports, and research letters) published in the Chinese Medical Joal (CMJ) from January 2000 to December 2009 evaluating TCM and other natural products were reviewed.The United Kingdom Clinical Research Collaboration (UK-CRC) Health Research Classification System was used to analyze the type of health research conducted. Further analysis on the major illnesses addressed and the major herbal components utilized was conducted.Results One hundred and seventeen original research reports involving TCM or other natural products were identified,comprising 3.82% of the CMJ output in the period covered by this study. Of the different materia medica described in these reports, 74.4% were derived exclusively from plant material, 10.3% from animals, 3.4% from fungi, 1.7% from minerals, and 10.3% were of mixed (plant / animal / fungal / mineral) composition. Twelve herbs were investigated exclusively or were constituents of 66/87 (75.9%) of the plant-based materia medica investigated. Panax ginseng was the most commonly investigated herb or constituent (14/87, 16.1%), followed by Astragalus membranaceus (9/87, 10.3%),Coptis chinensis/Berberis spp. (7/87, 8.0%) and Rheum spp. (7/87, 8.0%). Four UK-CRC health categories accounted for the majority of TCM and other natural product research (cancer, 20.9%; cardiovascular, 19.2%; oral/gastrointestinal,9.8%; and inflammatory/immune, 9.0%). The most common research activity was development of treatments and therapeutic interventions, which was undertaken by 103/117 (88.0%) of the research investigations reported. Human clinical trials involving natural products accounted for only 5.31% of the reported studies.Conclusions This is a relatively early systematic description of published research from a single joumal related to TCM and other natural products. The majority of the research reports described preliminary findings and very few controlled clinical trials in human subjects were reported. Further applied studies will be required to demonstrate the clinical effectiveness, utility and cost-effectiveness of TCM and natural products in clinical practice. The UK-CRC health research classification system is a useful tool for evaluating published research output and could be applied to describe the output from other joals, national and provincial funding bodies, charities, and non-govmental organizations involved in supporting health-related research.
其他文献
目的评价肝炎后高胆红素血症的疗效。方法回顾性分析18例肝炎后高胆红素血症的临床及治疗情况。结果4周后18例患者血清TBil、Dbil均降至正常;临床随访6个月,全部患者ALT和AST
目的探讨经Wiltse肌间隙入路联合伤椎置钉短节段椎弓根螺钉固定治疗无神经损伤胸腰段骨折的疗效。方法回顾性研究2013年11月至2015年1月采用Wiltse肌间隙入路与传统剥离椎旁肌入路分别联合伤椎置钉治疗胸腰段骨折的48例患者资料,Wiltse肌间隙入路的患者为A组(24例),传统剥离椎旁肌入路的患者为B组(24例)。两组患者术前一般资料比较差异无统计学意义(P> 0.05),具有可比性。比较
期刊
Background Wall shear stress is an important factor in the destabilization of atherosclerotic plaques. The purpose of this study was to assess the distribution
目的评价早、晚服用施慧达对原发性高血压的降压疗效及毒副反应。方法将原发性高血压患者68例随机分为两组(分别命名为晨组与晚组),按2.5~5.0mg/d剂量分别于早餐或晚餐0.5h后
目的 研究黄芪对进展期寻常型银屑病患者血浆IL-6、IL-8与IL-10水平的影响.方法 采用放射免疫法检测57例进展期寻常型银屑病患者用黄芪治疗前后血浆IL-6、IL-8与IL-10水平的
尿白蛋白(UA)检测用于筛查高危患者(高血压、糖尿病等)早期肾损伤已得到公认.临床在常检测24hUA定量来确定高血压早期肾损伤.但24h尿液标本收集耗费时间较长、患者依从性较差
期刊
抗中性粒细胞胞浆抗体(anti-neutrophil cytoplastic anti-bodies,ANCA)代表了一组与中性粒细胞胞浆成分反应的自身抗体,对活动性Wegener肉芽肿的诊断有较高的敏感性和特异性